GILD RSI
As of date:4/15/2021
GILD stock price:65.77
GILD RSI:60.30
Extremely
Overbought
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)60.30
Extremely
Oversold

Also see:
GILD Market Cap History
GILD Shares Outstanding History
GILD YTD Return
GILD DMA
GILD MACD
GILD Technical Analysis

Try ChartSweeps today

Notable Two Hundred Day Moving Average Cross - SFIX
16 hours, 42 minutes ago


LX Crosses Below Key Moving Average Level
16 hours, 42 minutes ago


MeiraGTx Holdings (MGTX) Shares Cross Above 200 DMA
16 hours, 42 minutes ago


Advent Technologies Holdings Breaks Below 200-Day Moving Average - Notable for ADN
16 hours, 42 minutes ago


SSTI Makes Bullish Cross Above Critical Moving Average
16 hours, 43 minutes ago


Laureate Education (LAUR) Shares Cross Above 200 DMA
16 hours, 57 minutes ago


Notable Two Hundred Day Moving Average Cross - SEDG
16 hours, 58 minutes ago


Bullish Two Hundred Day Moving Average Cross - LOCO
16 hours, 58 minutes ago


Aeglea BioTherapeutics (AGLE) Shares Cross Above 200 DMA
16 hours, 58 minutes ago


ViacomCBS (VIAC) Shares Cross Below 200 DMA
17 hours, 3 minutes ago


Notable Two Hundred Day Moving Average Cross - OFLX
17 hours, 9 minutes ago


SBA Communications Breaks Above 200-Day Moving Average - Bullish for SBAC
17 hours, 11 minutes ago


EBIX Crosses Below Key Moving Average Level
17 hours, 16 minutes ago


UAVS Makes Notable Cross Below Critical Moving Average
17 hours, 16 minutes ago


iShares J.P. Morgan EM Corporate Bond Breaks Above 200-Day Moving Average - Bullish for CEMB
17 hours, 35 minutes ago


More Technical Analysis News

GILD RSIGILD DMA
Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include viral diseases, inflammatory diseases and oncology. Co.'s products include: Biktarvy® for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), for the treatment of Coronavirus Disease 2019 requiring hospitalization; Epclusa® for the treatment of chronic hepatitis C virus infection; Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease; Yescarta® (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

When researching a stock like Gilead Sciences, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from GILD Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for GILD stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of these ways is called the Relative Strength Index, or RSI. This popular indicator, originally developed in the 1970's by J. Welles Wilder, looks at a 14-day moving average of a stock's gains on its up days, versus its losses on its down days. The resulting GILD RSI is a value that measures momentum, oscillating between "oversold" and "overbought" on a scale of zero to 100. A reading below 30 is viewed to be oversold, which a bullish investor could look to as a sign that the selling is in the process of exhausting itself, and look for entry point opportunities. A reading above 70 is viewed to be overbought, which could indicate that a rally in progress is starting to get crowded with buyers. If the rally has been a long one, that could be a sign that a pullback is overdue.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Quotes delayed 20 minutes
Get Free SEC filing alerts for GILD:
GILD SEC Filing Email Alerts ServiceExternal link
Video: RSI Indicator


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Gilead Sciences (GILD) is categorized under the Healthcare sector; to help you further research RSI, below are some other companies in the same sector:

HCA RSI
HOLX RSI
HSIC RSI
IDXX RSI
ILMN RSI
INCY RSI
IQV RSI
ISRG RSI
JNJ RSI
LH RSI
More Healthcare companies »

 

GILD RSI | www.StockRSI.com | Copyright © 2019 - 2021, All Rights Reserved

Nothing in StockRSI.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.